97 related articles for article (PubMed ID: 23682624)
1. Serum soluble fas ligand levels in familial Mediterranean fever.
Ceri M; Unverdi S; Senes M; Altay M; Yilmaz R; Yucel D; Duranay M
Ren Fail; 2013 Jul; 35(6):835-7. PubMed ID: 23682624
[TBL] [Abstract][Full Text] [Related]
2. Serum adenosine deaminase activities during acute attacks and attack-free periods of familial Mediterranean fever.
Kisacik B; Akdogan A; Yilmaz G; Karadag O; Yilmaz FM; Koklu S; Yuksel O; Ertenli AI; Kiraz S
Eur J Intern Med; 2009 Jan; 20(1):44-7. PubMed ID: 19237091
[TBL] [Abstract][Full Text] [Related]
3. Serum 17-OH progesterone and free testosterone levels in women patients with Familial Mediterranean Fever: a pivotal study.
Deveci K; Gokakin AK; Boztosun A; Deveci H; Senel S; Uslu AU; Sancakdar E
Eur Rev Med Pharmacol Sci; 2013 Jan; 17(2):261-5. PubMed ID: 23377818
[TBL] [Abstract][Full Text] [Related]
4. Higher Pentraxin-3 Levels are Associated With Inflammation in Familial Mediterranean Fever.
Bulut M; Ceri M; Unverdi S; Altay M; Senes M; Ecemis ZA; Duranay M
J Clin Lab Anal; 2016 Nov; 30(6):978-981. PubMed ID: 27790798
[TBL] [Abstract][Full Text] [Related]
5. Serum leptin is not a diagnostic marker for familial Mediterranean fever attacks.
Toy B; Tarçin O; Bağci S; Ustündağ Y; Inal A; Tiftikçi A
Mediators Inflamm; 2006; 2006(2):62868. PubMed ID: 16883064
[TBL] [Abstract][Full Text] [Related]
6. Does immune activation continue during an attack-free period in familial Mediterranean fever?
Musabak U; Sengul A; Oktenli C; Pay S; Yesilova Z; Kenar L; Sanisoglu SY; Inal A; Tuzun A; Erdil A; Bagci S
Clin Exp Immunol; 2004 Dec; 138(3):526-33. PubMed ID: 15544632
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of pentraxin-3 in familial Mediterranean fever patients during attack and attack-free periods.
Gok M; Sirkeci O; Kara M; Sakin YS; Tanoglu A; Sirkeci EE; Oztin H; Duzenli T; Kaplan M; Yazgan Y; Ipcioglu OM
Bratisl Lek Listy; 2018; 119(8):490-493. PubMed ID: 30160156
[TBL] [Abstract][Full Text] [Related]
8. Effect of Helicobacter pylori infection and eradication therapy on interleukin-6 levels in patients with Familial Mediterranean Fever.
Ozel AM; Demirturk L; Aydogdu A; Gultepe M; Yazgan Y; Imirzalioglu N; Gurbuz AK; Narin Y
Int J Clin Pract; 2008 May; 62(5):754-61. PubMed ID: 17343670
[TBL] [Abstract][Full Text] [Related]
9. Increased serum concentrations of homocysteine and lipoprotein (a) in familial Mediterranean fever.
Karatay S; Yildirim K; Uyanik A; Uzkeser H; Kiziltunc A; Ugur M; Baygutalp F; Acemoglu H
Ann Clin Lab Sci; 2010; 40(1):10-4. PubMed ID: 20124324
[TBL] [Abstract][Full Text] [Related]
10. Serum interleukin 17 and interleukin 18 levels in familial Mediterranean fever.
Haznedaroglu S; Oztürk MA; Sancak B; Goker B; Onat AM; Bukan N; Ertenli I; Kiraz S; Calguneri M
Clin Exp Rheumatol; 2005; 23(4 Suppl 38):S77-80. PubMed ID: 16273770
[TBL] [Abstract][Full Text] [Related]
11. Does mean platelet volume influence the attack or attack-free period in the patients with Familial Mediterranean fever?
Sahin S; Senel S; Ataseven H; Yalcin I
Platelets; 2013; 24(4):320-3. PubMed ID: 22720903
[TBL] [Abstract][Full Text] [Related]
12. Cystatin C in serum as an early marker of renal involvement in Familial Mediterranean Fever patients.
Deveci K; Gokakin AK; Senel S; Deveci H; Uslu AU; Sancakdar E
Eur Rev Med Pharmacol Sci; 2013 Jan; 17(2):253-60. PubMed ID: 23377817
[TBL] [Abstract][Full Text] [Related]
13. Serum sIL-2r, IL-6, IL-10 and TNF-alpha level in familial Mediterranean fever patients.
Baykal Y; Saglam K; Yilmaz MI; Taslipinar A; Akinci SB; Inal A
Clin Rheumatol; 2003 May; 22(2):99-101. PubMed ID: 12740672
[TBL] [Abstract][Full Text] [Related]
14. Neuroendocrine immune system in familial Mediterranean fever.
Topaloğlu R; Bilginer Y; Alikaşifoğlu A; Ozaltin F; Beşbaş N; Ozen S; Bakkaloğlu A
Turk J Pediatr; 2010; 52(6):588-93. PubMed ID: 21428190
[TBL] [Abstract][Full Text] [Related]
15. Can serum fetuin-A be regarded as an inflammatory marker among patients with familial Mediterranean fever?
Oncu K; Yazgan Y; Tanoglu A; Kaplan M; Ermis F; Ipcioglu OM; Kara M; Kucuk I; Ozari HO
Dig Dis Sci; 2013 Nov; 58(11):3212-7. PubMed ID: 23925820
[TBL] [Abstract][Full Text] [Related]
16. Macrophage inflammatory protein-1alpha: a link between innate immunity and familial Mediterranean fever?
Dizdar O; Kalyoncu U; Karadag O; Akdogan A; Kiraz S; Ertenli I; Barista I; Calguneri M
Cytokine; 2007 Jan; 37(1):92-5. PubMed ID: 17270460
[TBL] [Abstract][Full Text] [Related]
17. Co-existence of Helicobacter pylori infection in patients with Familial Mediterranean Fever (FMF) and the effect of Helicobacter pylori on the frequency and severity of FMF attacks.
Demirtürk L; Ozel AM; Cekem K; Yazgan Y; Gultepe M
Dig Liver Dis; 2005 Mar; 37(3):153-8. PubMed ID: 15888278
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of S100A12 protein levels in children with familial Mediterranean fever.
Türkmenoğlu Y; Güney E; Bezen D; İrdem A; Ertürk B; Dursun H
Turk J Med Sci; 2021 Jun; 51(3):1396-1405. PubMed ID: 33576586
[TBL] [Abstract][Full Text] [Related]
19. Increased soluble FAS suggests delayed apoptosis in familial Mediterranean fever complicated with amyloidosis.
Kiraz S; Ertenli I; Oztürk MA; Haznedaroglu IC; Calgüneri M; Atalar E; Ozbalkan Z; Kirazli S; Celik I
J Rheumatol; 2003 Feb; 30(2):313-5. PubMed ID: 12563687
[TBL] [Abstract][Full Text] [Related]
20. Anti-cyclic citrullinated peptide antibodies are not associated with familial Mediterranean fever.
Karatay S; Yildirim K; Erdal A; Uzkeser H; Erdem FH; Yanmaz V
J Back Musculoskelet Rehabil; 2010; 23(1):21-3. PubMed ID: 20231785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
